Nuvectis Pharma, Inc. NVCT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s shares (diluted)?
- Nuvectis Pharma, Inc. (NVCT) reported shares (diluted) of 23.4M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s shares (diluted) changed year-over-year?
- Nuvectis Pharma, Inc.'s shares (diluted) increased by 17.4% year-over-year, from 19.9M to 23.4M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s shares (diluted) has grown at a 50.3% compound annual growth rate (CAGR), from 16.8M to 85.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.